MediPharm Labs Launches LABS CANNABIS, A New and Innovative Family of Health and Wellness Products

BARRIE, Ontario, Oct. 20, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the launch of its new “LABS Cannabis” family of health and wellness products. Specially designed and formulated for theContinue reading “MediPharm Labs Launches LABS CANNABIS, A New and Innovative Family of Health and Wellness Products”

Emerald Health Therapeutics Launches Flavoured Cannabis Oils, Expanding SYNC(TM) Product Line

Combination of appealing natural flavourings and terpenes offers unique consumer experience Emerald also launches new SYNC CBD nanoemulsion-based Fast Action Spray in BC and Saskatchewan Vancouver, British Columbia–(Newsfile Corp. – October 19, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) has expanded its SYNCTM product line with the launch of new uniquely flavoured CBDContinue reading “Emerald Health Therapeutics Launches Flavoured Cannabis Oils, Expanding SYNC(TM) Product Line”

Indiva Secures Agreement with Medical Cannabis by Shoppers Inc.

Medical Cannabis by Shoppers™ portal to offer Bhang® Chocolate and Wana™ Sour Gummies LONDON, Ontario, Oct. 13, 2020 (GLOBE NEWSWIRE) — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce an agreement has been secured with Medical Cannabis by Shoppers Inc., a subsidiary ofContinue reading “Indiva Secures Agreement with Medical Cannabis by Shoppers Inc.”

MediPharm Labs Secures 100% Ownership of its Australia Subsidiary, Poised for New Wave of Global Medicinal Cannabis Growth

TORONTO, Sept. 28, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it has entered into a share sale and purchase agreement (the “Buyout Agreement”) with its local Australian partner to acquire its 20% ownershipContinue reading “MediPharm Labs Secures 100% Ownership of its Australia Subsidiary, Poised for New Wave of Global Medicinal Cannabis Growth”

Tilray Medical Cannabis Product Shows Promise Reducing Nausea and Vomiting Caused by Chemotherapy in World First Clinical Trial

NANAIMO, B.C.–(BUSINESS WIRE)–Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that Australian researchers have published preliminary results finding that one of the company’s GMP-produced products is showing promise reducing nausea and vomiting for cancer patients undergoing chemotherapy in a world’s first clinical trial. “so improving the control of nauseaContinue reading “Tilray Medical Cannabis Product Shows Promise Reducing Nausea and Vomiting Caused by Chemotherapy in World First Clinical Trial”

Supreme Cannabis Announces Financial Results for Q4 and Full-year 2020

Established a platform for strong revenue growth and operational efficiency with a strengthened balance sheet 2020 Fourth Quarter Highlights: Increased recreational sales net revenue by 27% quarter-over-quarter and 373% year-over-year, supported by brand expansion and the introduction of Cannabis 2.0 products 36 active retail SKUs listed, with presence in all 10 provinces Completed the firstContinue reading “Supreme Cannabis Announces Financial Results for Q4 and Full-year 2020”

WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020

Non-dilutive financing to fund continued growth including accelerating sales of Color Cannabis adult-use products and Starseed’s unique medical service offerings to payor groups and patients Company financials will now be filed on September 30, 2020 with management-hosted earnings call on October 1, 2020 at 10 a.m. EST — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensedContinue reading “WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020”

MediPharm Labs Enters Brazil – Latin America’s Largest Medical Cannabis Market in Partnership with XLR8 Brazil

 — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary MediPharm Labs Inc. will supply premium, GMP-certified formulated cannabis oil to XLR8 BRAZIL (“XLR8”), a Rio de Janeiro based value-added distributor serving Brazil, Latin America’sContinue reading “MediPharm Labs Enters Brazil – Latin America’s Largest Medical Cannabis Market in Partnership with XLR8 Brazil”

Greenwich Biosciences to Share Results of Cannabis Use Survey Conducted with the North American Research Committee on Multiple Sclerosis (NARCOMS) at Joint ACTRIMS-ECTRIMS Meeting, MSVirtual2020

– Nearly one-third of survey respondents indicated use of THC-containing cannabis for Multiple Sclerosis (MS) symptom management — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences, will present results of a survey conducted inContinue reading “Greenwich Biosciences to Share Results of Cannabis Use Survey Conducted with the North American Research Committee on Multiple Sclerosis (NARCOMS) at Joint ACTRIMS-ECTRIMS Meeting, MSVirtual2020”